Q/C Technologies Inc. (QCLS)
QCLS trades on Nasdaq in Health Care, Biotechnology: In Vitro & In Vivo Diagnostic Substances. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.5465
-5.79% on the day
Market cap
$4.5M
Nano cap
Revenue
No annual revenue filed since the period ending 2019-12-31
Net income
No annual revenue filed since the period ending 2019-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | QCLS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Country | United States |
| IPO year | 2014 |
| SEC CIK | 0001321834 |
| SEC industry code | In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2019-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-02-11 |
| Latest annual report | 10-K/A | 2026-04-29 |
| Latest quarterly / interim | 10-Q | 2026-08-12 |
| Latest current report | 8-K | 2026-09-18 |
| Latest proxy | DEF 14A | 2025-10-20 |
Source: SEC EDGAR submissions feed, 604 recent filings. All filings on EDGAR.
Peers in Biotechnology: In Vitro & In Vivo Diagnostic Substances
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| TRIB | Trinity Biotech plc | $6.30 | -3.96% | $5.1M |
| CDIO | Cardio Diagnostics Holdings Inc. | $1.75 | -1.69% | $5.2M |
| VNRX | VolitionRX Limited | $0.1847 | -9.06% | $5.6M |
| BMRA | Biomerica Inc. | $1.85 | +0.82% | $8.5M |
| VRAX | Virax Biolabs Group Limited | $1.74 | -6.05% | $2.3M |
| IMDX | Insight Molecular Diagnostics Inc. | $2.99 | -5.68% | $97.8M |
| ICCC | ImmuCell Corporation | $10.79 | +12.40% | $98.0M |
| MYGN | Myriad Genetics Inc. | $4.08 | -2.86% | $390.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier